Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Dokumenter

  • Fulltext

    Accepteret manuskript, 492 KB, PDF-dokument

  • Hertzel C. Gerstein
  • Emil Wolsk
  • Brian Claggett
  • Rafael Diaz
  • Kenneth Dickstein
  • Sibylle Hess
  • Køber, Lars Valeur
  • Aldo P. Maggioni
  • John J.V. McMurray
  • Jeffrey L. Probstfield
  • Matthew C. Riddle
  • Jean Claude Tardif
  • Marc A. Pfeffer
OriginalsprogEngelsk
TidsskriftDiabetes, Obesity and Metabolism
Vol/bind25
Udgave nummer4
Sider (fra-til)1125-1129
Antal sider5
ISSN1462-8902
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
The ELIXA trial was funded by Sanofi.

ID: 359084834